State Board of Administration of Florida Retirement System held its stake in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 71,830 shares of the medical instruments supplier’s stock at the close of the second quarter. State Board of Administration of Florida Retirement System owned about 0.12% of OraSure Technologies worth $1,240,000 at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the stock. BNP Paribas Arbitrage SA grew its position in OraSure Technologies by 58.7% in the second quarter. BNP Paribas Arbitrage SA now owns 17,005 shares of the medical instruments supplier’s stock worth $294,000 after acquiring an additional 6,287 shares during the period. Legal & General Group Plc grew its position in OraSure Technologies by 13.4% in the second quarter. Legal & General Group Plc now owns 104,506 shares of the medical instruments supplier’s stock worth $1,805,000 after acquiring an additional 12,367 shares during the period. Alps Advisors Inc. grew its position in OraSure Technologies by 0.3% in the second quarter. Alps Advisors Inc. now owns 43,257 shares of the medical instruments supplier’s stock worth $747,000 after acquiring an additional 111 shares during the period. Rhumbline Advisers grew its position in OraSure Technologies by 2.3% in the second quarter. Rhumbline Advisers now owns 106,594 shares of the medical instruments supplier’s stock worth $1,840,000 after acquiring an additional 2,428 shares during the period. Finally, First Mercantile Trust Co. purchased a new position in OraSure Technologies in the second quarter worth approximately $104,000. Institutional investors own 92.10% of the company’s stock.
TRADEMARK VIOLATION WARNING: “State Board of Administration of Florida Retirement System Continues to Hold Holdings in OraSure Technologies, Inc. (OSUR)” was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.chaffeybreeze.com/2017/09/19/state-board-of-administration-of-florida-retirement-system-continues-to-hold-holdings-in-orasure-technologies-inc-osur.html.
In other news, CFO Ronald H. Spair sold 510,112 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $20.66, for a total transaction of $10,538,913.92. Following the completion of the sale, the chief financial officer now directly owns 208,606 shares in the company, valued at approximately $4,309,799.96. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Brian Smith sold 9,112 shares of the company’s stock in a transaction on Thursday, August 31st. The stock was sold at an average price of $20.47, for a total value of $186,522.64. Following the sale, the insider now owns 32,477 shares of the company’s stock, valued at $664,804.19. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 960,173 shares of company stock valued at $18,752,210. Insiders own 6.40% of the company’s stock.
OraSure Technologies, Inc. (NASDAQ:OSUR) opened at 21.97 on Tuesday. OraSure Technologies, Inc. has a 52-week low of $7.09 and a 52-week high of $22.25. The stock has a market capitalization of $1.31 billion, a price-to-earnings ratio of 40.61 and a beta of 1.57. The stock’s 50 day moving average price is $20.60 and its 200 day moving average price is $16.11.
OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported $0.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.07 by $0.02. The company had revenue of $40.18 million during the quarter, compared to the consensus estimate of $36.54 million. OraSure Technologies had a return on equity of 15.64% and a net margin of 22.29%. OraSure Technologies’s revenue was up 28.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.07 EPS. On average, analysts forecast that OraSure Technologies, Inc. will post $0.48 EPS for the current year.
Several research analysts recently weighed in on OSUR shares. Stephens reiterated an “overweight” rating and issued a $19.00 price objective (up from $14.00) on shares of OraSure Technologies in a research report on Tuesday, July 11th. BidaskClub lowered OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 24th. Zacks Investment Research upgraded OraSure Technologies from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research report on Saturday, September 9th. Jefferies Group LLC increased their price objective on OraSure Technologies from $16.00 to $19.00 and gave the stock a “buy” rating in a research report on Wednesday, June 28th. Finally, Canaccord Genuity increased their price objective on OraSure Technologies from $15.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, June 28th. Three analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $16.46.
OraSure Technologies Profile
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).
Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.